Literature DB >> 7704967

Plasma catecholamines in patients with Addison's disease.

S R Bornstein1, M Breidert, M Ehrhart-Bornstein, B Kloos, W A Scherbaum.   

Abstract

BACKGROUND AND
OBJECTIVE: Two endocrine tissues are present within the adrenal gland: the steroid producing cortical cells and the catecholamine producing chromaffin cells. Glucocorticoids occur in high concentrations in the adrenal medulla. In vitro, glucocorticoids have been shown to induce the enzyme phenyl-N-methyl-transferase which is necessary for the production of adrenaline in adrenal medullary cells. The purpose of this study was to evaluate the possible significance of a local glucocorticoid effect on adrenomedullary function.
DESIGN: Plasma catecholamine levels were measured in patients with autoimmune Addison's disease where local production of corticosteroids is deficient in the presence of intact chromaffin tissue. MEASUREMENTS: Catecholamines were measured by high pressure liquid chromatography and ACTH, renin and adrenal steroids by radioimmunoassay. PATIENTS: Nineteen Addisonian patients (9 females, 10 males) were treated according to a standard regime with oral cortisone acetate (37.5 mg/day) and fludrocortisone (0.1 mg/day). All patients were clinically well.
RESULTS: Mean plasma adrenaline in patients with Addison's disease was significantly reduced compared to a sex and age matched control group (males (n = 10) 143 +/- 36 pmol/l, controls (n = 27) 303 +/- 30 pmol/l, P < 0.01; females (n = 9) 77 +/- 25 pmol/l, controls (n = 27) 293 +/- 21 pmol, P < 0.001). The noradrenaline:adrenaline ratio was clearly higher in patients with Addison's disease (males 24 +/- 4, controls 9 +/- 1, P < 0.01; females 45 +/- 6, controls 9 +/- 1, P < 0.01).
CONCLUSION: We conclude that the physiologically high local glucocorticoid concentration may be responsible for normal adrenaline production under basal conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704967     DOI: 10.1111/j.1365-2265.1995.tb01866.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

Review 1.  Diagnosis and treatment of ACTH deficiency.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

2.  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.

Authors:  C M R Germano; M de Castro; J C Crescencio; L Gallo; J Antunes-Rodrigues; A C Moreira; L L K Elias
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 3.  Clinical catecholamine neurochemistry: a legacy of Julius Axelrod.

Authors:  David S Goldstein; Graeme Eisenhofer; Irwin J Kopin
Journal:  Cell Mol Neurobiol       Date:  2006-07-27       Impact factor: 5.046

4.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

5.  Ramadan fasting in patients with adrenal insufficiency.

Authors:  Mélika Chihaoui; Fatma Chaker; Meriem Yazidi; Wafa Grira; Zohra Ben Amor; Ons Rejeb; Hedia Slimane
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

6.  Cortisol-dependent stress effects on cell distribution in healthy individuals and individuals suffering from chronic adrenal insufficiency.

Authors:  Ashley M Geiger; Kenneth P Pitts; Joachim Feldkamp; Clemens Kirschbaum; Jutta M Wolf
Journal:  Brain Behav Immun       Date:  2015-07-14       Impact factor: 7.217

7.  Addisonian crisis in a young man with atypical anorexia nervosa.

Authors:  Bruno Allolio; Katharina Lang; Stefanie Hahner
Journal:  Nat Rev Endocrinol       Date:  2010-12-21       Impact factor: 43.330

Review 8.  Cortical-chromaffin cell interactions in the adrenal gland.

Authors:  Sven Schinner; Stefan R Bornstein
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 9.  Past, present and future of human chromaffin cells: role in physiology and therapeutics.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Almudena Albillos
Journal:  Cell Mol Neurobiol       Date:  2010-11-24       Impact factor: 5.046

Review 10.  [Addison's disease : Primary adrenal insufficiency].

Authors:  A Pulzer; S Burger-Stritt; S Hahner
Journal:  Internist (Berl)       Date:  2016-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.